Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda J Krebs

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|November 13, 2004
Calcimimetics and hyperparathyroidismLinda J Krebs
The Journal of Clinical Endocrinology and Metabolism|June 16, 2005
HRPT2 mutational analysis of typical sporadic parathyroid adenomasLinda J Krebs, Trisha M Shattuck, Andrew Arnold
International Journal of Oncology|November 14, 2002
Bombesin and epidermal growth factor potentiate the effect of cytotoxic LH-RH analog AN-152 in vitroLinda J Krebs, Xiaopeng Wang, Atilla Nagy, et al.
Oral Oncology|October 2, 2002
A conjugate of doxorubicin and an analog of Luteinizing Hormone-Releasing Hormone shows increased efficacy against oral and laryngeal cancersLinda J Krebs, Xiaopeng Wang, Attila Nagy, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2002
Molecular pathogenesis of primary hyperparathyroidismAndrew Arnold, Trisha M Shattuck, Sanjay M Mallya, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Opinion in Investigational Drugs (London, England : 2000)|November 13, 2004
Calcimimetics and hyperparathyroidismLinda J Krebs
The Journal of Clinical Endocrinology and Metabolism|June 16, 2005
HRPT2 mutational analysis of typical sporadic parathyroid adenomasLinda J Krebs, Trisha M Shattuck, Andrew Arnold
International Journal of Oncology|November 14, 2002
Bombesin and epidermal growth factor potentiate the effect of cytotoxic LH-RH analog AN-152 in vitroLinda J Krebs, Xiaopeng Wang, Atilla Nagy, et al.
Oral Oncology|October 2, 2002
A conjugate of doxorubicin and an analog of Luteinizing Hormone-Releasing Hormone shows increased efficacy against oral and laryngeal cancersLinda J Krebs, Xiaopeng Wang, Attila Nagy, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2002
Molecular pathogenesis of primary hyperparathyroidismAndrew Arnold, Trisha M Shattuck, Sanjay M Mallya, et al.
Pageof 1